October 24, 2016 5:56 PM ET


Company Overview of Quark Pharmaceuticals, Inc.

Key Executives for Quark Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Daniel Zurr Ph.D.20 RelationshipsFounder, Chief Executive Officer, President, Director and Member of Compensation Committee70
Tomer Natan LLM, BB, CPANo RelationshipsChief Financial Officer--
Rami Skaliter Ph.D.3 RelationshipsChief Operating Officer58
Shai S. Erlich Ph.D.No RelationshipsChief Medical Officer50
Juliana Friedmann M.Sc.No RelationshipsSenior Vice President of Strategy & Planning64

Quark Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Philip B. Simon J.D., CPA 20 RelationshipsLawrence Investments, LLC63
Daniel Zurr Ph.D. 20 RelationshipsQuark Pharmaceuticals, Inc.70
Philip M. Hahn 20 RelationshipsQuark Pharmaceuticals, Inc.74
André G. Pernet Ph.D., M.B.A 45 RelationshipsGenset Corporation71
Dov Weinberger M.D. 20 RelationshipsQuark Pharmaceuticals, Inc.--
View All Board Members

Quark Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., CPAPhilip B. Simon20 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$457.3K
Compensation as of Fiscal Year 2010
Quark Pharmaceuticals, Inc. CEO Compensation
Industry Average


Rhinomed Limited Announces Resignation of Justine Heath as Chief Financial Officer and Chief Operating Officer
October 23, 2016 10:23 PM ET
Cynapsus Therapeutics Inc. Announces Management Changes
October 21, 2016 9:26 PM ET
Mark L. Thompson to Step Down as Chief Executive Officer and Chairman of Concordia International Corp
October 21, 2016 5:55 PM ET
Dechra Pharmaceuticals plc Announces Executive Changes
October 21, 2016 6:00 AM ET
Scot L. Harper, Vice President of Clinical Operations, to Leave Endocyte, Inc., Effective October 28, 2016
October 20, 2016 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Quark Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.